FDA promotes NAT (nucleic acid testing) for HIV-1/HCV testing
This article was originally published in Clinica
Executive Summary
Now that nucleic acid testing (NAT) is available, the US FDA has issued a guidance document to ensure that blood centres take advantage of the latest nucleic acid tests to detect the presence of HIV-1 or HCV.